Enliven Therapeutics, Inc.ELVNNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-104.55M
↓ 175% below average
Average (7y)
$-38.08M
Historical baseline
Range
High:$-8.90M
Low:$-104.55M
CAGR
+42.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-104.55M | -25.2% |
| 2023 | $-83.53M | -115.3% |
| 2022 | $-38.79M | -56.7% |
| 2021 | $-24.76M | -165.7% |
| 2020 | $-9.32M | +61.4% |
| 2019 | $-24.12M | -125.9% |
| 2018 | $-10.68M | -19.9% |
| 2017 | $-8.90M | - |